Skip to main content

Press

   

 Third Annual Conference on Brain Metastases

Now Accepting Abstracts
Submission Deadline: April 26, 2021, 11:59 PM EST

Submit Your Abstract


Overview
Join the Society for Neuro-Oncology, in association with the AANS/CNS Section on Tumors, for the 3rd Annual Conference on Brain Metastases on August 19-21, 2021.

Registration
Registration for the conference will open soon.

Who Should Attend
Neuro-oncologist, medical oncologist, neurosurgeons, radiation oncologist, radiologist, physicians/scientists, clinical and laboratory trainees, allied health professionals, pharmacists, and other medical professionals with an interest in metastatic disease.

Abstract Submission Categories
The conference organizers welcome the submission of original research on the following topics:
  • Basic Science
  • Leptomeningeal Disease
  • Clinical Trials
  • Medical Therapy (Chemotherapy and Immunotherapy)
  • Multimodality
  • Radiation
  • Surgery
  • Other
What to Expect
  • Lectures, Q&A sessions, posters, and poster discussions
  • Opportunities to engage with industry and nonprofit partners
  • Accepted abstracts to be published in SNO's journal, Neuro-Oncology-Advances
  • Networking opportunities
Learning Objectives
  • Indicate all available treatment options for management of LMD patients. 
  • Identify methods to assess QOL and any factors that may contribute to a decline in QOL.  
  • Summarize unique issues in the design of clinical trials for brain metastases. 
  • Recognize LITT as a treatment option for brain metastases. 
  • Identify immunotherapy options for treatment of brain metastases. Lectures, Q&A sessions, posters, and poster discussion.
Scientific Program Co-Chairs
Adrienne Boire 
Memorial Sloan Kettering Cancer Center
New York, NY

Paul Kongkham
University of Toronto
Toronto, ON

Rohan Ramakrishna
Weill Cornell Medicine
Brooklyn, NY

David Shultz
University of Toronto
Toronto, ON

Important Information
At the present time, we are planning to hold this conference as planned. We will continue to monitor the situation and adjust our plans if necessary.
 

Quick Links